Phase 2 Hepatocellular Cancer Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma+4 more
Pfizer138 enrolled35 locationsNCT07227012
Recruiting
Phase 1Phase 2
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Breast CancerEsophageal CancerPancreatic Cancer+13 more
ModeX Therapeutics, An OPKO Health Company285 enrolled6 locationsNCT06239194
Recruiting
Phase 1Phase 2
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Colorectal, CancerHepatocellular CarcinomaMelanoma+15 more
7 Hills Pharma, LLC126 enrolled5 locationsNCT06362369
Recruiting
Phase 2
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Colorectal, CancerColorectal CarcinomaHepatocellular Carcinoma+2 more
National Cancer Centre, Singapore60 enrolled1 locationNCT04912765
Recruiting
Phase 2
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Pancreatic CancerBiliary Tract CancerCholangiocarcinoma+1 more
AHS Cancer Control Alberta62 enrolled1 locationNCT05451043
Recruiting
Phase 2
Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
Liver CancerHepatocellular CarcinomaHepatocellular Cancer+2 more
Asan Medical Center138 enrolled1 locationNCT05992220
Recruiting
Phase 2
mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC
Stage III Hepatocellular Cancer (CNLC Staging)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University35 enrolled1 locationNCT05412589